Sporadic inclusion body myositis: Diagnostic value of p62 immunostaining
- 26 June 2019
- journal article
- research article
- Published by Elsevier BV in Medicina Clinica
- Vol. 153 (11), 437-440
- https://doi.org/10.1016/j.medcli.2019.04.022
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Inclusion Body MyositisCONTINUUM: Lifelong Learning in Neurology, 2016
- Diagnostic criteria for inclusion body myositisJournal of Internal Medicine, 2016
- Inclusion body myositis: A review of clinical and genetic aspects, diagnostic criteria and therapeutic approachesJournal of Clinical Neuroscience, 2015
- Evaluation and construction of diagnostic criteria for inclusion body myositisNeurology, 2014
- A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositisBMJ Open, 2014
- Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological featuresJournal of Neurology, Neurosurgery & Psychiatry, 2013
- Polymyositis and dermatomyositis: Disease spectrum and classificationIndian Journal of Dermatology, 2012
- Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBMNeurology, 2008
- Polymyositis and DermatomyositisThe New England Journal of Medicine, 1975